Summary
Boston Scientific Corporation (BSX) filed an 8-K on February 1, 2011, to announce its financial results for the fourth quarter and full year ended December 31, 2010. This filing primarily serves as a notification that a press release containing these financial details was issued on the same date and is furnished as part of the report. Investors should refer to the press release (Exhibit 99.1) for the specific financial performance, including revenue, earnings, and any forward-looking guidance provided by the company. While the 8-K itself does not contain the detailed financial figures, its purpose is to make the official earnings announcement readily accessible. Investors relying on this filing should seek out the associated press release for a comprehensive understanding of Boston Scientific's operational and financial condition as of year-end 2010, which would include key metrics impacting the company's valuation and future prospects.
Key Highlights
- 1Boston Scientific Corporation (BSX) announced its fourth quarter and full year 2010 financial results.
- 2The results were disclosed via a press release dated February 1, 2011.
- 3This 8-K filing officially furnishes the press release as Exhibit 99.1.
- 4Investors are directed to the press release for specific financial data and operational performance.
- 5The filing pertains to the period ending December 31, 2010.
- 6Information furnished under Item 2.02 and Exhibit 99.1 is not considered 'filed' for certain SEC liability purposes.